PCSK9 Antibody-based Treatment Strategies for Patients With Statin Intolerance

Conclusion: PCSK9 inhibition can be considered as a treatment of option for lipid-lowering in statin-intolerant patients.

Source: In Vivo - January 5, 2021 Category: Research Authors: VOUTYRITSA, E., DAMASKOS, C., FARMAKI, P., KYRIAKOS, G., DIAMANTIS, E., QUILES-SANCHEZ, L. V., GARMPI, A., GARMPIS, N., PATSOURAS, A., STELIANIDI, A., SAVVANIS, S. Tags: Reviews Source Type: research